Up next

Autoplay

The future of CTCL therapy

2 Views • 08/09/23
Share
Embed
administrator
administrator
Subscribers
0

Julia Jane Scarisbrick, MBChB, FRCP, MD, University Hospital Birmingham, Birmingham, UK, shares her views on the future of cutaneous T-cell lymphoma (CTCL) therapy, highlighting the unmet need for more efficacious therapies and to determine the optimal sequencing of therapies. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay